Clinical Trials Browser

OTHER × CRC × Clear all

NCT07204574 2025-10-02

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

Phase 1/2 Recruiting

CRC

NCT03336658 2024-11-13

ITB

Active not recruiting

CRC

NCT05314309 2023-01-11

mtFIT

14,712 enrolled

CRC

NCT05382377 2022-05-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

CRC

NCT03337776 2021-08-05

Effect of WhatsApp Messenger on Uptake of CRC Screening Study

Phase NA Withdrawn

CRC

NCT03601598 2018-07-26

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

Phase 1/2 Unknown

CRC